Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.31978386 |
2 | response to muramyl dipeptide (GO:0032495) | 5.01267211 |
3 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.00330183 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93385578 |
5 | regulation of vitamin metabolic process (GO:0030656) | 4.85554441 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.77897748 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.77897748 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.77897748 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.77897748 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.77897748 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.77897748 |
12 | activation of MAPKKK activity (GO:0000185) | 4.75087281 |
13 | response to peptidoglycan (GO:0032494) | 4.73205208 |
14 | T-helper 1 type immune response (GO:0042088) | 4.70348714 |
15 | regulation of mononuclear cell migration (GO:0071675) | 4.40890426 |
16 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.35989276 |
17 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.32608394 |
18 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.28916181 |
19 | positive regulation of heat generation (GO:0031652) | 4.25826245 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 4.24378377 |
21 | regulation of podosome assembly (GO:0071801) | 3.99270503 |
22 | response to protozoan (GO:0001562) | 3.95922942 |
23 | positive regulation of interferon-alpha production (GO:0032727) | 3.89535644 |
24 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.88678062 |
25 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.84209630 |
26 | regulation of fever generation (GO:0031620) | 3.81971302 |
27 | modulation by symbiont of host cellular process (GO:0044068) | 3.80672741 |
28 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.80040907 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79064922 |
30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76439915 |
31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.74959839 |
32 | cellular response to interferon-beta (GO:0035458) | 3.74108439 |
33 | regulation of interferon-alpha production (GO:0032647) | 3.74080760 |
34 | defense response to protozoan (GO:0042832) | 3.73818281 |
35 | macrophage activation involved in immune response (GO:0002281) | 3.73441954 |
36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72844533 |
37 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.67331846 |
38 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.67073571 |
39 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64547027 |
40 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.63961792 |
41 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.63629583 |
42 | immunoglobulin mediated immune response (GO:0016064) | 3.61861401 |
43 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.60805654 |
44 | regulation of chronic inflammatory response (GO:0002676) | 3.59563299 |
45 | granulocyte activation (GO:0036230) | 3.59516593 |
46 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.55285886 |
47 | natural killer cell mediated immunity (GO:0002228) | 3.55285886 |
48 | NIK/NF-kappaB signaling (GO:0038061) | 3.55045909 |
49 | cellular response to virus (GO:0098586) | 3.54483885 |
50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.51725780 |
51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49301909 |
52 | negative regulation of lipid storage (GO:0010888) | 3.47257969 |
53 | neutrophil activation (GO:0042119) | 3.47254642 |
54 | monocyte chemotaxis (GO:0002548) | 3.46660818 |
55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.45781193 |
56 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.44411695 |
57 | B cell mediated immunity (GO:0019724) | 3.43977474 |
58 | cellular response to exogenous dsRNA (GO:0071360) | 3.39976211 |
59 | cellular response to interferon-gamma (GO:0071346) | 3.37954762 |
60 | * positive regulation of interleukin-12 production (GO:0032735) | 3.35349804 |
61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33822748 |
62 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.33062138 |
63 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.31918576 |
64 | T cell lineage commitment (GO:0002360) | 3.29740784 |
65 | myeloid cell activation involved in immune response (GO:0002275) | 3.29541281 |
66 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.28959429 |
67 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28855711 |
68 | regulation of activation of Janus kinase activity (GO:0010533) | 3.28664412 |
69 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.25456397 |
70 | T cell migration (GO:0072678) | 3.25249746 |
71 | regulation of T-helper cell differentiation (GO:0045622) | 3.24805130 |
72 | cellular response to nicotine (GO:0071316) | 3.22927006 |
73 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.22664589 |
74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.22184627 |
75 | respiratory burst (GO:0045730) | 3.22078583 |
76 | positive regulation of type 2 immune response (GO:0002830) | 3.20387031 |
77 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.20096116 |
78 | response to interferon-beta (GO:0035456) | 3.19364233 |
79 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18321070 |
80 | B cell proliferation (GO:0042100) | 3.18109262 |
81 | positive regulation of humoral immune response (GO:0002922) | 3.17883060 |
82 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.15749334 |
83 | regulation of heat generation (GO:0031650) | 3.12793061 |
84 | regulation of chemokine biosynthetic process (GO:0045073) | 3.11548353 |
85 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.09998117 |
86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08851406 |
87 | negative regulation of viral genome replication (GO:0045071) | 3.08570621 |
88 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.08468841 |
89 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08135979 |
90 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.08014865 |
91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07910129 |
92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07048498 |
93 | eosinophil chemotaxis (GO:0048245) | 3.06197113 |
94 | positive regulation of B cell mediated immunity (GO:0002714) | 3.05950831 |
95 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.05950831 |
96 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.05687519 |
97 | response to interferon-gamma (GO:0034341) | 3.05485921 |
98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.05113455 |
99 | germinal center formation (GO:0002467) | 3.05085276 |
100 | positive regulation of defense response to virus by host (GO:0002230) | 3.04716128 |
101 | cell adhesion mediated by integrin (GO:0033627) | 3.04463946 |
102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03099609 |
103 | response to host immune response (GO:0052572) | 3.03099609 |
104 | negative regulation of interleukin-17 production (GO:0032700) | 3.02705398 |
105 | positive regulation of interleukin-2 production (GO:0032743) | 3.00370844 |
106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00089322 |
107 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.99743849 |
108 | regulation of immunoglobulin secretion (GO:0051023) | 2.99525532 |
109 | cellular response to molecule of bacterial origin (GO:0071219) | 2.98819601 |
110 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97892115 |
111 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.97467649 |
112 | superoxide anion generation (GO:0042554) | 2.97428305 |
113 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.96725931 |
114 | negative regulation of amino acid transport (GO:0051956) | 2.96706395 |
115 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.96448580 |
116 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.96008614 |
117 | regulation of B cell apoptotic process (GO:0002902) | 2.96001695 |
118 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.95708612 |
119 | wound healing, spreading of epidermal cells (GO:0035313) | 2.95587298 |
120 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93824834 |
121 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.93616896 |
122 | leukocyte mediated cytotoxicity (GO:0001909) | 2.93567755 |
123 | positive regulation of interferon-beta production (GO:0032728) | 2.93280947 |
124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.92827755 |
125 | microglial cell activation (GO:0001774) | 2.92804291 |
126 | * regulation of interleukin-12 production (GO:0032655) | 2.92510941 |
127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.91516126 |
128 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.91131763 |
129 | negative regulation of growth of symbiont in host (GO:0044130) | 2.90466358 |
130 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.90466358 |
131 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.90466358 |
132 | regulation of growth of symbiont in host (GO:0044126) | 2.90466358 |
133 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.90342912 |
134 | positive regulation of interleukin-10 production (GO:0032733) | 2.89754253 |
135 | type I interferon signaling pathway (GO:0060337) | 2.89610136 |
136 | cellular response to type I interferon (GO:0071357) | 2.89610136 |
137 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.89516135 |
138 | positive regulation of B cell proliferation (GO:0030890) | 2.88498369 |
139 | positive regulation of protein homooligomerization (GO:0032464) | 2.88261614 |
140 | detection of molecule of bacterial origin (GO:0032490) | 2.88138213 |
141 | positive regulation of mast cell activation (GO:0033005) | 2.87204494 |
142 | leukocyte aggregation (GO:0070486) | 2.85990040 |
143 | neutrophil mediated immunity (GO:0002446) | 2.85907296 |
144 | * myeloid dendritic cell differentiation (GO:0043011) | 2.85565513 |
145 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.85321939 |
146 | positive regulation of mast cell degranulation (GO:0043306) | 2.85321939 |
147 | response to type I interferon (GO:0034340) | 2.85165239 |
148 | positive regulation of lymphocyte migration (GO:2000403) | 2.84791212 |
149 | lymphocyte chemotaxis (GO:0048247) | 2.84755414 |
150 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.83590162 |
151 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.83458740 |
152 | cellular response to lipopolysaccharide (GO:0071222) | 2.83039464 |
153 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.82584946 |
154 | * myeloid dendritic cell activation (GO:0001773) | 2.80864585 |
155 | regulation of antigen processing and presentation (GO:0002577) | 2.79742547 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.63163253 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.43570940 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.33865121 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20879303 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.20685374 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.14088422 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.91873311 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.70214479 |
9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.63070091 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60286087 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54302866 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44285211 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.35348665 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18961990 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.18601359 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13519715 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85143602 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67883510 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.59327882 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58638562 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39759246 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20826719 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.14556932 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10506901 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08436459 |
26 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.06095983 |
27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95840600 |
28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93974953 |
29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.92704774 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89970001 |
31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89317877 |
32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84368014 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.80169377 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78808053 |
35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77187148 |
36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75834050 |
37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69948131 |
38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69288143 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64457668 |
40 | MYB_26560356_Chip-Seq_TH2_Human | 1.61018585 |
41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58875732 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57372299 |
43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56188043 |
44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55077457 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50456582 |
46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49174519 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47859541 |
48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47376657 |
49 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.47099861 |
50 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46712395 |
51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46142155 |
52 | MAF_26560356_Chip-Seq_TH1_Human | 1.42969972 |
53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40201417 |
54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37445690 |
55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36350513 |
56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35102564 |
57 | MYB_26560356_Chip-Seq_TH1_Human | 1.34650440 |
58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34027667 |
59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30957002 |
60 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.25703368 |
61 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24737126 |
62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23855583 |
63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23716597 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23308212 |
65 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23055693 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22137675 |
67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.22117809 |
68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17913013 |
69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17913013 |
70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17648161 |
71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17629996 |
72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15174544 |
73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11895743 |
74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11830853 |
75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10842620 |
76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10666494 |
77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09968382 |
78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09917274 |
79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09800385 |
80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09682807 |
81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08632865 |
82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08518201 |
83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07811170 |
84 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07235189 |
85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06931081 |
86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06857395 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04869184 |
88 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04535197 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04461458 |
90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.03286218 |
91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.02985857 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01605656 |
93 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00288214 |
94 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99481746 |
95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98549965 |
96 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97340798 |
97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94713007 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94089410 |
99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93832953 |
100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93734997 |
101 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.93458407 |
102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90830719 |
103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90593750 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90515937 |
105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90260801 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90209185 |
107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89688000 |
108 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.88899420 |
109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88677610 |
110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88622924 |
111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88493687 |
112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87825093 |
113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87710132 |
114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87274941 |
115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86316168 |
116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86316168 |
117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85898189 |
118 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85126956 |
119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85097640 |
120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84710399 |
121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83921957 |
122 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81608525 |
123 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80146290 |
124 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79451285 |
125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79048654 |
126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76794231 |
127 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76584298 |
128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74548832 |
129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73863672 |
130 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73434790 |
131 | MAF_26560356_Chip-Seq_TH2_Human | 0.72379477 |
132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70665753 |
133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69112121 |
134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64143436 |
135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.63598437 |
136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62810349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.84802437 |
2 | MP0003436_decreased_susceptibility_to | 3.91342214 |
3 | MP0002148_abnormal_hypersensitivity_rea | 3.78845870 |
4 | MP0009785_altered_susceptibility_to | 3.58580794 |
5 | MP0006082_CNS_inflammation | 3.47013857 |
6 | MP0005000_abnormal_immune_tolerance | 3.40104625 |
7 | MP0003303_peritoneal_inflammation | 3.38698556 |
8 | MP0002419_abnormal_innate_immunity | 3.16503170 |
9 | MP0005387_immune_system_phenotype | 2.99750175 |
10 | MP0001790_abnormal_immune_system | 2.99750175 |
11 | MP0000685_abnormal_immune_system | 2.88356384 |
12 | MP0005025_abnormal_response_to | 2.86460068 |
13 | MP0005671_abnormal_response_to | 2.83618638 |
14 | MP0002452_abnormal_antigen_presenting | 2.76690965 |
15 | MP0001800_abnormal_humoral_immune | 2.70479057 |
16 | MP0005451_abnormal_body_composition | 2.65767169 |
17 | MP0002723_abnormal_immune_serum | 2.63468443 |
18 | MP0000569_abnormal_digit_pigmentation | 2.54240990 |
19 | MP0004510_myositis | 2.45851314 |
20 | MP0004947_skin_inflammation | 2.38406415 |
21 | * MP0001819_abnormal_immune_cell | 2.25814121 |
22 | * MP0002420_abnormal_adaptive_immunity | 2.22167406 |
23 | MP0005058_abnormal_lysosome_morphology | 2.16620370 |
24 | MP0001853_heart_inflammation | 2.16297073 |
25 | MP0002139_abnormal_hepatobiliary_system | 2.11165764 |
26 | MP0009278_abnormal_bone_marrow | 2.08520573 |
27 | MP0003724_increased_susceptibility_to | 2.05290960 |
28 | MP0003448_altered_tumor_morphology | 1.98333572 |
29 | MP0005464_abnormal_platelet_physiology | 1.98214314 |
30 | MP0009764_decreased_sensitivity_to | 1.95696794 |
31 | MP0001845_abnormal_inflammatory_respons | 1.87212073 |
32 | MP0003172_abnormal_lysosome_physiology | 1.86337743 |
33 | MP0002405_respiratory_system_inflammati | 1.81131470 |
34 | MP0010155_abnormal_intestine_physiology | 1.80309890 |
35 | MP0001533_abnormal_skeleton_physiology | 1.78902982 |
36 | MP0005257_abnormal_intraocular_pressure | 1.73879525 |
37 | MP0002006_tumorigenesis | 1.72634103 |
38 | MP0005310_abnormal_salivary_gland | 1.62124431 |
39 | MP0001545_abnormal_hematopoietic_system | 1.56320543 |
40 | MP0005397_hematopoietic_system_phenotyp | 1.56320543 |
41 | MP0000716_abnormal_immune_system | 1.56188830 |
42 | MP0008004_abnormal_stomach_pH | 1.55418860 |
43 | MP0008469_abnormal_protein_level | 1.54569715 |
44 | MP0005076_abnormal_cell_differentiation | 1.51878280 |
45 | MP0002398_abnormal_bone_marrow | 1.48710324 |
46 | MP0000858_altered_metastatic_potential | 1.44072619 |
47 | MP0000343_altered_response_to | 1.43188489 |
48 | MP0005174_abnormal_tail_pigmentation | 1.35900457 |
49 | MP0009840_abnormal_foam_cell | 1.30348811 |
50 | MP0002254_reproductive_system_inflammat | 1.29035461 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.28409448 |
52 | MP0001851_eye_inflammation | 1.26724650 |
53 | MP0002998_abnormal_bone_remodeling | 1.26379907 |
54 | MP0002166_altered_tumor_susceptibility | 1.26375755 |
55 | MP0000689_abnormal_spleen_morphology | 1.25567835 |
56 | MP0003690_abnormal_glial_cell | 1.24320527 |
57 | MP0002429_abnormal_blood_cell | 1.21766328 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.21517552 |
59 | MP0003300_gastrointestinal_ulcer | 1.15105159 |
60 | MP0003806_abnormal_nucleotide_metabolis | 1.12512504 |
61 | MP0000604_amyloidosis | 1.12466595 |
62 | MP0002722_abnormal_immune_system | 1.11697684 |
63 | MP0004782_abnormal_surfactant_physiolog | 1.11109944 |
64 | MP0002877_abnormal_melanocyte_morpholog | 1.08904926 |
65 | MP0003656_abnormal_erythrocyte_physiolo | 1.06805209 |
66 | MP0003566_abnormal_cell_adhesion | 1.05359261 |
67 | MP0005167_abnormal_blood-brain_barrier | 1.04656044 |
68 | MP0003828_pulmonary_edema | 1.04429713 |
69 | MP0009763_increased_sensitivity_to | 1.03219209 |
70 | MP0003075_altered_response_to | 1.02867450 |
71 | MP0003091_abnormal_cell_migration | 1.02688127 |
72 | MP0005166_decreased_susceptibility_to | 1.01199961 |
73 | MP0003183_abnormal_peptide_metabolism | 0.97265955 |
74 | MP0005165_increased_susceptibility_to | 0.96921382 |
75 | MP0002933_joint_inflammation | 0.94849878 |
76 | MP0005164_abnormal_response_to | 0.94561959 |
77 | MP0004381_abnormal_hair_follicle | 0.91647968 |
78 | MP0010307_abnormal_tumor_latency | 0.91047452 |
79 | MP0005390_skeleton_phenotype | 0.90798381 |
80 | MP0001958_emphysema | 0.89983978 |
81 | MP0001348_abnormal_lacrimal_gland | 0.89321022 |
82 | MP0000015_abnormal_ear_pigmentation | 0.88068997 |
83 | MP0001542_abnormal_bone_strength | 0.87668655 |
84 | MP0002138_abnormal_hepatobiliary_system | 0.86875144 |
85 | MP0000249_abnormal_blood_vessel | 0.82742122 |
86 | MP0006054_spinal_hemorrhage | 0.82232622 |
87 | MP0005647_abnormal_sex_gland | 0.81485926 |
88 | MP0008874_decreased_physiological_sensi | 0.81052429 |
89 | MP0002277_abnormal_respiratory_mucosa | 0.80546640 |
90 | MP0005023_abnormal_wound_healing | 0.79885661 |
91 | MP0003763_abnormal_thymus_physiology | 0.79700780 |
92 | MP0000371_diluted_coat_color | 0.78970201 |
93 | MP0008260_abnormal_autophagy | 0.77025205 |
94 | MP0005623_abnormal_meninges_morphology | 0.76312179 |
95 | MP0001873_stomach_inflammation | 0.72520558 |
96 | MP0010352_gastrointestinal_tract_polyps | 0.71513826 |
97 | MP0001727_abnormal_embryo_implantation | 0.70540390 |
98 | MP0009765_abnormal_xenobiotic_induced | 0.70517856 |
99 | MP0005666_abnormal_adipose_tissue | 0.70014196 |
100 | MP0005266_abnormal_metabolism | 0.69351164 |
101 | MP0001663_abnormal_digestive_system | 0.69141529 |
102 | MP0000490_abnormal_crypts_of | 0.68589389 |
103 | MP0003191_abnormal_cellular_cholesterol | 0.67756756 |
104 | MP0004883_abnormal_blood_vessel | 0.67318125 |
105 | MP0003950_abnormal_plasma_membrane | 0.66346580 |
106 | MP0000703_abnormal_thymus_morphology | 0.64167176 |
107 | MP0004808_abnormal_hematopoietic_stem | 0.63697686 |
108 | MP0003795_abnormal_bone_structure | 0.61592972 |
109 | MP0000920_abnormal_myelination | 0.61578124 |
110 | MP0001216_abnormal_epidermal_layer | 0.59939178 |
111 | MP0002019_abnormal_tumor_incidence | 0.59844189 |
112 | MP0005197_abnormal_uvea_morphology | 0.59835613 |
113 | MP0000627_abnormal_mammary_gland | 0.57796758 |
114 | MP0002136_abnormal_kidney_physiology | 0.57214936 |
115 | MP0002693_abnormal_pancreas_physiology | 0.57169035 |
116 | MP0003045_fibrosis | 0.56720254 |
117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56261009 |
118 | MP0000609_abnormal_liver_physiology | 0.56049537 |
119 | MP0005535_abnormal_body_temperature | 0.55691086 |
120 | MP0001501_abnormal_sleep_pattern | 0.55317210 |
121 | MP0000767_abnormal_smooth_muscle | 0.54788301 |
122 | MP0001191_abnormal_skin_condition | 0.54403223 |
123 | MP0002163_abnormal_gland_morphology | 0.52637436 |
124 | MP0003866_abnormal_defecation | 0.52391422 |
125 | MP0005083_abnormal_biliary_tract | 0.51198134 |
126 | MP0002332_abnormal_exercise_endurance | 0.50703579 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.53869737 |
2 | Recurrent bacterial skin infections (HP:0005406) | 7.09096018 |
3 | Eczematoid dermatitis (HP:0000976) | 6.24033781 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.58372784 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.37117645 |
6 | Stomatitis (HP:0010280) | 5.36647455 |
7 | Gastrointestinal stroma tumor (HP:0100723) | 5.15655229 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 5.14884640 |
9 | Abnormality of macrophages (HP:0004311) | 4.98028789 |
10 | Vacuolated lymphocytes (HP:0001922) | 4.41462487 |
11 | IgA deficiency (HP:0002720) | 4.40890822 |
12 | Thick nail (HP:0001805) | 4.31924124 |
13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.26381520 |
14 | Increased cerebral lipofuscin (HP:0011813) | 4.17537332 |
15 | Recurrent skin infections (HP:0001581) | 4.13959852 |
16 | Gingivitis (HP:0000230) | 4.08442852 |
17 | Optic neuritis (HP:0100653) | 3.90680002 |
18 | Retrobulbar optic neuritis (HP:0100654) | 3.90680002 |
19 | Prostate neoplasm (HP:0100787) | 3.90318012 |
20 | Myositis (HP:0100614) | 3.83401040 |
21 | Systemic lupus erythematosus (HP:0002725) | 3.82421676 |
22 | Orchitis (HP:0100796) | 3.79973618 |
23 | Recurrent fungal infections (HP:0002841) | 3.64049249 |
24 | Pustule (HP:0200039) | 3.59537345 |
25 | Loss of speech (HP:0002371) | 3.57631732 |
26 | Axonal loss (HP:0003447) | 3.53270369 |
27 | Periodontitis (HP:0000704) | 3.43602612 |
28 | Vasculitis (HP:0002633) | 3.38369984 |
29 | Autoimmune thrombocytopenia (HP:0001973) | 3.23963123 |
30 | Nuclear cataract (HP:0100018) | 3.17877627 |
31 | Increased IgM level (HP:0003496) | 3.17299500 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16193692 |
33 | Obstructive lung disease (HP:0006536) | 3.16193692 |
34 | Lymphopenia (HP:0001888) | 3.15116287 |
35 | Emphysema (HP:0002097) | 3.11744914 |
36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10630187 |
37 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10630187 |
38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10630187 |
39 | Interstitial pulmonary disease (HP:0006530) | 3.07328485 |
40 | Basal ganglia calcification (HP:0002135) | 3.05037532 |
41 | Pulmonary infiltrates (HP:0002113) | 3.03235298 |
42 | Recurrent viral infections (HP:0004429) | 3.02776390 |
43 | Hematochezia (HP:0002573) | 3.01952167 |
44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.01282665 |
45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.98311203 |
46 | Leukocytosis (HP:0001974) | 2.95946904 |
47 | Recurrent sinusitis (HP:0011108) | 2.88333465 |
48 | Recurrent bronchitis (HP:0002837) | 2.81638918 |
49 | Cellulitis (HP:0100658) | 2.80093834 |
50 | Parakeratosis (HP:0001036) | 2.79055883 |
51 | Autoimmune hemolytic anemia (HP:0001890) | 2.78900124 |
52 | Gangrene (HP:0100758) | 2.78022681 |
53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.77517744 |
54 | Osteomyelitis (HP:0002754) | 2.72998180 |
55 | Disinhibition (HP:0000734) | 2.71706511 |
56 | Urticaria (HP:0001025) | 2.69005081 |
57 | Amyloidosis (HP:0011034) | 2.68211042 |
58 | Mutism (HP:0002300) | 2.64062725 |
59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62566824 |
60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62566824 |
61 | Increased serum ferritin (HP:0003281) | 2.59710473 |
62 | Anhidrosis (HP:0000970) | 2.57478246 |
63 | Dysostosis multiplex (HP:0000943) | 2.54212857 |
64 | Vertebral compression fractures (HP:0002953) | 2.53717982 |
65 | Hypertensive crisis (HP:0100735) | 2.53378235 |
66 | IgG deficiency (HP:0004315) | 2.48911775 |
67 | Osteolytic defects of the hand bones (HP:0009699) | 2.48419165 |
68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.48419165 |
69 | Glomerulonephritis (HP:0000099) | 2.45922499 |
70 | Premature loss of primary teeth (HP:0006323) | 2.42363920 |
71 | Increased IgE level (HP:0003212) | 2.41837619 |
72 | Meningitis (HP:0001287) | 2.38639857 |
73 | B lymphocytopenia (HP:0010976) | 2.38449105 |
74 | Apathy (HP:0000741) | 2.37932312 |
75 | Gingival bleeding (HP:0000225) | 2.37873116 |
76 | IgM deficiency (HP:0002850) | 2.35702553 |
77 | Abnormality of the prostate (HP:0008775) | 2.35043929 |
78 | Abnormality of the pleura (HP:0002103) | 2.30291791 |
79 | Encephalitis (HP:0002383) | 2.29613327 |
80 | Bone pain (HP:0002653) | 2.25442363 |
81 | Abnormality of B cell number (HP:0010975) | 2.25026946 |
82 | Recurrent pneumonia (HP:0006532) | 2.24963324 |
83 | Progressive neurologic deterioration (HP:0002344) | 2.23191491 |
84 | Diminished motivation (HP:0000745) | 2.22001763 |
85 | Arterial thrombosis (HP:0004420) | 2.20472808 |
86 | Polyneuropathy (HP:0001271) | 2.20052589 |
87 | Pathologic fracture (HP:0002756) | 2.19893689 |
88 | Pulmonary artery stenosis (HP:0004415) | 2.19217609 |
89 | Agnosia (HP:0010524) | 2.17996683 |
90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17265064 |
91 | Hypergammaglobulinemia (HP:0010702) | 2.16701948 |
92 | Hemoptysis (HP:0002105) | 2.15948962 |
93 | Eosinophilia (HP:0001880) | 2.15275443 |
94 | Neurofibrillary tangles (HP:0002185) | 2.14231729 |
95 | Petechiae (HP:0000967) | 2.11908592 |
96 | Keratoconjunctivitis sicca (HP:0001097) | 2.09835103 |
97 | Keratitis (HP:0000491) | 2.08692597 |
98 | Abnormality of the pericardium (HP:0001697) | 2.05280317 |
99 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.04922622 |
100 | Chronic otitis media (HP:0000389) | 2.04456074 |
101 | Colitis (HP:0002583) | 2.04052631 |
102 | Myocardial infarction (HP:0001658) | 2.03290550 |
103 | Purpura (HP:0000979) | 2.03053765 |
104 | Joint swelling (HP:0001386) | 2.02384026 |
105 | Neuronal loss in central nervous system (HP:0002529) | 2.01633602 |
106 | Cheilitis (HP:0100825) | 2.00988531 |
107 | Mucopolysacchariduria (HP:0008155) | 1.99967440 |
108 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99967440 |
109 | Abnormality of T cell number (HP:0011839) | 1.99644413 |
110 | Prolonged neonatal jaundice (HP:0006579) | 1.99639909 |
111 | Abnormality of the frontal sinuses (HP:0002687) | 1.99011946 |
112 | Leukopenia (HP:0001882) | 1.96683397 |
113 | Hepatosplenomegaly (HP:0001433) | 1.95826859 |
114 | Gastrointestinal infarctions (HP:0005244) | 1.95792080 |
115 | Thoracolumbar scoliosis (HP:0002944) | 1.95378281 |
116 | Conical tooth (HP:0000698) | 1.94907033 |
117 | Squamous cell carcinoma (HP:0002860) | 1.94202047 |
118 | Inflammation of the large intestine (HP:0002037) | 1.92847994 |
119 | Keratoconjunctivitis (HP:0001096) | 1.92622365 |
120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92171478 |
121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92171478 |
122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92171478 |
123 | Agammaglobulinemia (HP:0004432) | 1.91191626 |
124 | Personality changes (HP:0000751) | 1.91186266 |
125 | Nausea (HP:0002018) | 1.90662206 |
126 | Chronic diarrhea (HP:0002028) | 1.89736532 |
127 | Abnormality of T cell physiology (HP:0011840) | 1.89351223 |
128 | Poor head control (HP:0002421) | 1.89210395 |
129 | Anorexia (HP:0002039) | 1.88845868 |
130 | Peripheral demyelination (HP:0011096) | 1.87661735 |
131 | Glomerulopathy (HP:0100820) | 1.86757183 |
132 | Absent frontal sinuses (HP:0002688) | 1.86562084 |
133 | Abnormality of proline metabolism (HP:0010907) | 1.86177510 |
134 | Hydroxyprolinuria (HP:0003080) | 1.86177510 |
135 | Nephritis (HP:0000123) | 1.85998893 |
136 | Tetraparesis (HP:0002273) | 1.85869580 |
137 | Xerostomia (HP:0000217) | 1.84813361 |
138 | Stomach cancer (HP:0012126) | 1.83031543 |
139 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82895000 |
140 | T lymphocytopenia (HP:0005403) | 1.81829965 |
141 | Restrictive lung disease (HP:0002091) | 1.79962986 |
142 | Skin ulcer (HP:0200042) | 1.79347333 |
143 | Arthralgia (HP:0002829) | 1.79262586 |
144 | Abnormality of eosinophils (HP:0001879) | 1.77913545 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.12716782 |
2 | TBK1 | 3.94976883 |
3 | IRAK3 | 3.94591881 |
4 | RIPK4 | 3.23319672 |
5 | IKBKB | 3.19946752 |
6 | PRPF4B | 3.16507185 |
7 | IKBKE | 3.10757802 |
8 | IRAK4 | 2.94975040 |
9 | TYK2 | 2.86179865 |
10 | JAK3 | 2.52510204 |
11 | PIM2 | 2.47663376 |
12 | MAP4K1 | 2.41509774 |
13 | BMPR2 | 2.38723987 |
14 | DDR2 | 2.36796294 |
15 | MAP3K13 | 2.34781213 |
16 | TXK | 2.31093306 |
17 | KIT | 2.30034371 |
18 | CHUK | 2.19535507 |
19 | JAK1 | 1.82446197 |
20 | BLK | 1.76745272 |
21 | RIPK1 | 1.72514112 |
22 | PIM1 | 1.62452548 |
23 | TLK1 | 1.60257001 |
24 | MST4 | 1.44481764 |
25 | MAP3K11 | 1.44370127 |
26 | NME2 | 1.38067389 |
27 | EIF2AK2 | 1.37430843 |
28 | LATS2 | 1.34018544 |
29 | SMG1 | 1.33747340 |
30 | CDK12 | 1.33013797 |
31 | MAP3K3 | 1.32930055 |
32 | BMX | 1.32265983 |
33 | SYK | 1.31094116 |
34 | PBK | 1.28681588 |
35 | TAOK1 | 1.27069051 |
36 | TEC | 1.25963337 |
37 | ZAP70 | 1.25930087 |
38 | TAOK3 | 1.20953969 |
39 | CSF1R | 1.18438128 |
40 | HCK | 1.18066933 |
41 | ERBB3 | 1.17373838 |
42 | LCK | 1.14794692 |
43 | CSK | 1.12964943 |
44 | BTK | 1.12725190 |
45 | CDC42BPA | 1.08643121 |
46 | MAP2K3 | 1.05880278 |
47 | LYN | 1.03617862 |
48 | ABL2 | 1.01466217 |
49 | JAK2 | 0.98269103 |
50 | NEK9 | 0.95701594 |
51 | RPS6KA4 | 0.95378972 |
52 | TESK2 | 0.93538187 |
53 | ITK | 0.92350657 |
54 | ICK | 0.89940472 |
55 | TRPM7 | 0.89353010 |
56 | ERN1 | 0.88258443 |
57 | SIK3 | 0.87514334 |
58 | STK10 | 0.87330319 |
59 | MARK3 | 0.83812503 |
60 | TGFBR2 | 0.81684875 |
61 | VRK1 | 0.80864941 |
62 | PKN1 | 0.77533920 |
63 | FGR | 0.76967915 |
64 | SIK2 | 0.76350875 |
65 | MAP3K9 | 0.74990840 |
66 | BRAF | 0.73920093 |
67 | ABL1 | 0.73180782 |
68 | MAP3K5 | 0.72058000 |
69 | CLK1 | 0.71663055 |
70 | FES | 0.70515648 |
71 | MOS | 0.70441340 |
72 | MAP3K1 | 0.69957605 |
73 | PRKCD | 0.69866893 |
74 | TTN | 0.68673798 |
75 | HIPK2 | 0.68466501 |
76 | PDK2 | 0.66284376 |
77 | ARAF | 0.65499451 |
78 | RPS6KA5 | 0.65224485 |
79 | IRAK2 | 0.62241688 |
80 | EGFR | 0.61683524 |
81 | MAP3K8 | 0.61202456 |
82 | EEF2K | 0.60229875 |
83 | STK4 | 0.56725815 |
84 | SIK1 | 0.56333386 |
85 | MAPKAPK2 | 0.54866559 |
86 | CDK4 | 0.53970589 |
87 | EPHB1 | 0.53177512 |
88 | IRAK1 | 0.52762155 |
89 | TYRO3 | 0.52462105 |
90 | PTK6 | 0.51520127 |
91 | DAPK3 | 0.51407667 |
92 | MAPK11 | 0.50816421 |
93 | TAOK2 | 0.50060750 |
94 | BRD4 | 0.49707698 |
95 | LRRK2 | 0.48541102 |
96 | MST1R | 0.47923387 |
97 | CDK6 | 0.47413879 |
98 | EIF2AK3 | 0.47171493 |
99 | MAP3K10 | 0.45200943 |
100 | YES1 | 0.43338021 |
101 | AURKA | 0.42852192 |
102 | PRKCQ | 0.41834459 |
103 | MAPK7 | 0.41793261 |
104 | FLT3 | 0.40307973 |
105 | GRK7 | 0.39883356 |
106 | DYRK3 | 0.38801185 |
107 | RPS6KA6 | 0.38151828 |
108 | FGFR3 | 0.38022816 |
109 | TESK1 | 0.37747533 |
110 | RPS6KA2 | 0.36710024 |
111 | CCNB1 | 0.35931294 |
112 | DYRK1B | 0.35921450 |
113 | MATK | 0.35509372 |
114 | TRIB3 | 0.34841535 |
115 | PLK2 | 0.34512632 |
116 | PDGFRB | 0.32917484 |
117 | GSK3A | 0.32328401 |
118 | RPS6KA1 | 0.31095974 |
119 | MELK | 0.30028507 |
120 | PAK4 | 0.29487183 |
121 | STK24 | 0.29473465 |
122 | RPS6KL1 | 0.26918435 |
123 | RPS6KC1 | 0.26918435 |
124 | FYN | 0.25128747 |
125 | ZAK | 0.24941495 |
126 | PAK1 | 0.24524202 |
127 | PDK1 | 0.23577911 |
128 | STK3 | 0.23210168 |
129 | MAPK4 | 0.22490986 |
130 | INSR | 0.21804665 |
131 | IGF1R | 0.21155482 |
132 | PIK3CA | 0.20141785 |
133 | FGFR4 | 0.20091280 |
134 | SGK1 | 0.19255440 |
135 | ADRBK2 | 0.18681215 |
136 | SCYL2 | 0.18110289 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.90629907 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.18121122 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.12428314 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.92231845 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.91543200 |
6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.88635519 |
7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.53755738 |
8 | Legionellosis_Homo sapiens_hsa05134 | 2.44581508 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44166034 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36705101 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36475956 |
12 | Pertussis_Homo sapiens_hsa05133 | 2.33945051 |
13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32751641 |
14 | Malaria_Homo sapiens_hsa05144 | 2.29424462 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.23211600 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.21650053 |
17 | Asthma_Homo sapiens_hsa05310 | 2.18470963 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08661228 |
19 | Tuberculosis_Homo sapiens_hsa05152 | 2.05810415 |
20 | Measles_Homo sapiens_hsa05162 | 1.95010867 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80833324 |
22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.75518056 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.72354997 |
24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69320248 |
25 | Apoptosis_Homo sapiens_hsa04210 | 1.66709088 |
26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64383882 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.63662331 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.63250366 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.52057319 |
30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51711142 |
31 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50912643 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50378608 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45946250 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41378486 |
35 | Phagosome_Homo sapiens_hsa04145 | 1.41329848 |
36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32365641 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31578252 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.30865934 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30475739 |
40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25520838 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22556608 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20312618 |
43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20030906 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.17345318 |
45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14902185 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11218390 |
47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11036126 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 0.99658302 |
49 | Amoebiasis_Homo sapiens_hsa05146 | 0.96096243 |
50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95417113 |
51 | Bladder cancer_Homo sapiens_hsa05219 | 0.95120502 |
52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93940549 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90432649 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87695350 |
55 | Alcoholism_Homo sapiens_hsa05034 | 0.77794094 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72535486 |
57 | Prion diseases_Homo sapiens_hsa05020 | 0.72184108 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71771899 |
59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67064968 |
60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65801187 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64904347 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62527600 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61637361 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61061881 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60377708 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57732844 |
67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56839756 |
68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54515171 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53697671 |
70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51178601 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49346049 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47977079 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42663114 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.42359263 |
75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40760882 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39793481 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39347303 |
78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37258762 |
79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36773268 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35620839 |
81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34588462 |
82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34525833 |
83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33109511 |
84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31780506 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.31517735 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31371005 |
87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31109828 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30663435 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30648643 |
90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27941199 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26925115 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26127034 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25175009 |
94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23055750 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22612485 |
96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22577638 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20944162 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18880489 |
99 | Prostate cancer_Homo sapiens_hsa05215 | 0.17612798 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.14313368 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13275128 |
102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12857117 |
103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11668983 |
104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.10118142 |
105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.09202694 |
106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08292406 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08143127 |
108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08057162 |
109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06549587 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06272775 |
111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.05548178 |
112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.01386238 |